Quest Diagnostics Incorporated (DGX) recently delivered strong first-quarter results. Earnings per share of 89 cents topped the year-prior 72 cents and exceeded analysts’ expectations by 8.5%.

Company Description

Quest Diagnostics Incorporated provides diagnostic testing, information and services for patients and doctors all over the world. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers. Quest Diagnostics also provides interpretive consultation through its extensive medical and scientific staff. The company is consider to be a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

An Excellent Quarter

Quest Diagnostics recently delivered strong first-quarter results. Earnings per share of 89 cents topped the year-prior 72 cents and exceeded analysts’ expectations by 8.5%.

First quarter revenues jumped 1.3% to $1.8 billion on a year-over-year basis. Clinical testing revenues grew 2.2% from last year.

“We began the year with a strong first quarter, delivering a 24% increase in earnings per share,” said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer. “These results reflect our continued focus on growing esoteric testing Incorporatedluding cancer diagnostics, and our program to drive sustainable operating efficiencies, as well as effective cost management in the quarter. We are executing our plan, and for 2009 continue to expect revenue growth of 3%. Reflecting our strong performance in the quarter, today we are raising our guidance for earnings per share.”

The company hiked its full-year earnings guidance, which now ranges between $3.65 and $3.75 per share.
Analysts are looking for $3.69 per share, up from last month’s $3.58. For 2010, analysts are forecasting earnings of $3.99 per share, above the previous month’s $3.94.

Favorable Industry Comparisons

Quest Diagnostics offers a return on equity (ROE) of 18%, topping the industry’s average of 16%. The company’s net profit margin of 8% is ahead of the industry’s average of 6%. DGX rewards shareholders with a dividend, yielding an industry-leading 1%.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (BDX) Becton, Dickinson and Company – Growth And Income – Zacks Rank BuyBecton, Dickinson and Company (BDX) keeps seeing bullish forecasts on strong fundamentals as the company...
2. (GA) Giant Interactive Group Inc. – Growth And Income – Zacks Rank BuyGiant Interactive Group Inc. (GA) recently posted stellar results for the fourth quarter. Earnings per...
3. (STE) Steris Corp. – Growth And Income – Zacks Rank BuySteris Corp. (STE) continues to see higher forecasts from analysts. Current fiscal year earnings estimates...
4. (BDX) Becton Dickinson and Company – Growth And Income – Zacks Rank BuyBecton, Dickinson and Company (BDX) continues to see bullish forecasts from Wall Street. Analysts are...
5. (BBY) Best Buy Co. Inc. – Growth And Income – Zacks Rank BuyBest Buy Co. Inc. (BBY) is watching analysts boost earnings estimates as its share price...
6. (STE) Steris Corporation – Growth And Income – Zacks Rank BuySteris Corporation (STE) has produced impressive surprises on earnings, topping analysts’ EPS estimates by an...

Search Posts by Tag: DGX | Quest Diagnostics Inc. | Healthcare | Medical Laboratories & Research

RSS Feeds by Tag: DGX | Quest Diagnostics Inc. | Healthcare | Medical Laboratories & Research |

Other Posts by: vitalstocks | RSS Feed for this author